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Abstract
Sequence analysis of the genome of the strict intracellular pathogen Chlamydia trachomatis revealed the presence of a SET
domain containing protein, proteins that primarily function as histone methyltransferases. In these studies, we
demonstrated secretion of this protein via a type III secretion mechanism. During infection, the protein is translocated
to the host cell nucleus and associates with chromatin. We therefore named the protein nuclear effector (NUE). Expression
of NUE in mammalian cells by transfection reconstituted nuclear targeting and chromatin association. In vitro methylation
assays confirmed NUE is a histone methyltransferase that targets histones H2B, H3 and H4 and itself (automethylation).
Mutants deficient in automethylation demonstrated diminished activity towards histones suggesting automethylation
functions to enhance enzymatic activity. Thus, NUE is secreted by Chlamydia, translocates to the host cell nucleus and has
enzymatic activity towards eukaryotic substrates. This work is the first description of a bacterial effector that directly targets
mammalian histones.
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Introduction
Chlamydiae spp. are responsible for a variety of significant diseases
in both animals and humans. Chlamydia trachomatis is the most
prevalent sexually transmitted bacterial pathogen, infecting an
estimated 92 million people a year, and leads to severe pathologies
including infertility, ectopic pregnancy and pelvic inflammatory
disease. Additionally, C. trachomatis infection of the ocular
epithelium is the leading cause of blindness by an infectious agent
and C. pneumoniae is a prevalent respiratory pathogen that has been
implicated in coronary artery diseases [1].
Chlamydiae are obligate intracellular pathogens that target
epithelial cells and have a specific biphasic developmental cycle.
The infectious form of the bacteria, called elementary bodies (EBs),
are characterized by a rigid cell wall, densely packed DNA and
metabolic inactivity. Upon entry of a host cell, EBs rapidly convert
to reticulate bodies (RBs), the metabolically active but noninfectious
form of the bacteria. RBs replicate within a membrane-bound
vacuole in the host cell called an inclusion. The bacteria remain
withininclusionsuntiltheyeventuallyconvert backtoinfectiousEBs
and exit the host cell as a result of cell lysis or via fusion of the
inclusion with the cell membrane [2].
Like other pathogenic gram negative bacteria, C. trachomatis
encodes a type three secretion (TTS) system that enables the
translocation of proteins across a eukaryotic host membrane. In the
case of chlamydiae, TTS occurs both across the plasma membrane
during entry and across the inclusion membrane during the
intracellular developmental cycle. There are no common signal
sequences found in proteins secreted by TTS although it is generally
accepted that the signal islocated at the N-terminus [3]. It is therefore
infeasible to identify effector proteins by sequence alone. As
chlamydiae are intractable for genetic manipulation, it is also not
possible to identify secreted proteins using bacterial mutants. Despite
these experimental obstacles, several groups have identified chla-
mydial proteins secreted by TTS [4,5,6,7] Although the specific
function of most of these proteins remains unknown, they presumably
target various cellular processes and allow the bacteria to subvert host
defense mechanisms. To date, no such effectors have been found to
target the host cell nucleus.
The SET domain is a 130-residue domain originally defined in
proteins capable of changing the expression of heterochromatin-
embedded gene sequences [8]. Subsequent studies identified these
proteins as histone methyltransferases (HMTs) whose enzymatic
function is covalent attachment of methyl groups to lysine residues
of histones. A SET domain containing protein has been identified
in every eukaryote studied [9], yet these proteins are notably
underrepresented in prokaryotes presumably because they lack the
target substrate, histones. The majority of non-eukaryotic SET
domain proteins are found in species that interact with eukaryotes,
such as pathogenic bacteria or viruses. Although these enzymes
are generally presented as specific for one particular histone
modification, several reports have found multiple histone and/or
non-histone cellular substrates for a single SET domain protein
[10,11,12]. In some cases, this includes methylation of more than
one histone or methylation of multiple residues within a particular
histone [13,14,15]. Regardless of the substrate, all SET domain
proteins require the presence of S-adenosyl-L-methionine (SAM)
as the methyl donor.
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nucleosomes, a repeating unit of 146 bp of DNA encircling an
octamer of core histones (two copies each of H2A, H2B, H3 and
H4). Higher order chromatin structure is regulated in part by N-
terminal histone tails of the core histones that protrude from the
nucleosome and are available for inter-nucleosomal interactions.
These histone tails are the target of various post-translational
modifications including acetylation, phosphorylation, ubiquitina-
tion and methylation. Each of these modifications contributes to
reduced or enhanced accessibility of the transcriptional machinery
at a particular locus and ultimately dictates whether a gene is
expressed or repressed. The biological consequence of histone
methylation varies greatly depending on the targeted histone, the
specific lysine modified and the number of methyl groups added to
this lysine (mono-, di- or tri-methylation). The effects of these
modifications range from gene suppression to gene activation,
either directly due to a change in chromatin structure or indirectly
through the recruitment of additional modifying proteins [9,16].
Among histone modifications, methylation is thought to be a
relatively stable modification resulting in longterm changes in
cellular function. Once thought to be a permanent modification,
the growing number of histone demethylases being identified
suggests that histone methylation is a dynamic process [17,18].
Unlike eukaryotes, prokaryotes do not have histones nor highly
ordered chromatin. However, several reports have identified
histone-like proteins in bacteria [19]. The specific function of these
proteins remains largely undefined. Chlamydia trachomatis encodes
two histone-like proteins called histone H1-like chlamydial protein
1 and 2, or Hc1 and Hc2. Both are thought to play a critical role
in compacting bacterial DNA during the transition from RBs to
EBs [20,21,22]. The metabolic inactivity of EBs due to extreme
condensation of DNA is thought to be regulated by tight
interactions with Hc1 and Hc2. In support of this hypothesis,
Hc1 expression is decreased during the EB to RB transition which
corresponds temporally to the onset of transcriptional activity in
the bacteria [23].
Pathogenic bacteria employ a wide range of strategies to avoid
elimination by their host. Targeting histone modifications could
allow a pathogen to inhibit transcriptional activation of host
defense genes. In this study, we set out to characterize the
chlamydial SET domain protein CT737. We found the protein to
be secreted from bacteria and localized to the mammalian nucleus.
Additionally, we report its enzymatic activity as a histone
methyltransferase. Altogether, we propose to designate CT737
and its homologs in other chlamydiae genomes as NUE, as it is the
first nuclear effector identified in chlamydiae.
Results
NUE contains a conserved SET domain
Genomic analysis is a highly useful tool when studying protein
function of a genetically intractable pathogen such as chlamydiae.
Completion of the Chlamydia trachomatis genome sequence revealed
a SET domain in ORF 737 [24]. We analyzed the similarity of
CT737 (NUE) to a select number of mammalian SET domain
proteins (Fig. 1A). Within the predicted enzymatic portion of the
protein, we found between 14% and 28% sequence identity with
eukaryotic SET domain proteins, which is within the range of
similarity found among mammalian SET domain proteins
themselves. Importantly, the residues critical for enzymatic
function are highly conserved. This includes the SAM binding
site, the site of catalysis and the unique pseudoknot structure
required for enzyme function [25]. Additionally, we compared the
sequences of all six sequenced chlamydiae species, including the
two human pathogens C. trachomatis and C. pneumoniae. We found a
highly conserved homolog of CT737 in each (Fig. 1B), suggest-
ing that this protein plays an essential role in chlamydiae
development.
NUE is secreted from the bacteria to the host cell nucleus
Although chlamydiae are evolutionary distant from other gram
negative bacteria, we have successfully used a heterologous
machinery, i.e. the TTS system of Shigella flexneri to identify
chlamydial TTS substrates [4]. To test the hypothesis that NUE
might be a TTS effector protein, we fused the N-terminal
sequence of NUE to the reporter protein, calmodulin-dependent
adenylate cyclase (Cya). The chimeric protein was then expressed
in S. flexneri ipaB (constitutive TTS) or mxiD (deficient in TTS)
strains. When we analyzed the culture supernatant versus the
bacterial pellet, we found NUE primarily in the supernatant of
ipaB culture (Fig. 2A). The same expression pattern was observed
for the endogenous TTS substrate of Shigella, invasion plasmid
antigen D (IpaD). Conversely, we found cAMP receptor protein
(CRP), a non-secreted protein retained in S. flexneri, exclusively in
the bacterial pellet excluding the possibility of non-specific leaking
into the supernatant. This result demonstrates the NUE/Cya
chimera was secreted to the culture supernantant by the ipaB
strain. Furthermore, the chimera was found primarily in the
bacterial pellet when expressed in the mxiD strain, indicating
secretion occurs via TTS. Despite the impressive degree of NUE
sequence identity among chlamydiae (Fig. 1B), there is little
conservation in the N-terminal domain where the secretion signal
is located. To determine whether the SET domain protein of other
species also contained a TTS signal, we cloned the N-terminal
sequence of the NUE C. pneumoniae and C. caviae homologs
(Cpn0878 and CCA00889, respectively) upstream of the Cya
reporter. Both chimeras were secreted when expressed in TTS
constitutive but not TTS deficient S. flexneri (Fig. 2A). Due to the
poor conservation of the N-terminal sequence of NUE homologs,
finding three sequences that function as TTS signal is highly
indicative that chlamydiae SET domains proteins are TTS
effectors.
To determine the expression pattern of NUE during infection,
we generated an antibody specific for the protein (see Supple-
mentary Figure S1). Using this antibody for immunofluorescence
Author Summary
Chlamydia trachomatis is a particularly prevalent human
pathogen responsible for loss of eyesight through
trachoma and is the most common sexually transmitted
disease of bacterial origin. Unlike most other bacterial
pathogens, chlamydiae survive only within another cell
and thus must develop sophisticated mechanisms to
subvert immune clearance by their host. To this end, the
bacteria secrete proteins into the cells they occupy which
disrupt normal cellular function. In this work, we identify
one such protein, NUE, which is injected into the nucleus
of human cells during infection. Sequence analysis of NUE
revealed the presence of a SET domain which suggests its
involvement in chromatin remodeling. Indeed, we found
the protein associated with chromatin both during
infection and when transfected into human cells. Impor-
tantly, we demonstrate NUE is an active histone methyl-
transferase that targets host cell histones but does not
modify bacterial histone-like proteins. This is the first
bacterial protein identified which is able to penetrate the
nucleus and directly modify mammalian histones.
C. trachomatis NUE Methylates Histones
PLoS Pathogens | www.plospathogens.org 2 July 2010 | Volume 6 | Issue 7 | e1000995Figure 1. Sequence analysis of chlamydial SET domain protein. (A) The SET domain of chlamydial protein NUE (CT737) sequence was
compared to eukaryotic SET domain proteins G9a, MLL4, Set8 and Suv39H1. Residues important for SAM binding, catalysis and the structurally
important pseudoknot are noted. (B) Homologous SET domain proteins were compared for each of the 6 Chlamydia genomes sequenced, the SET
domain is underlined. ‘‘.’’ indicates a semi-conserved residue, ‘‘:’’ a conserved residue and ‘‘*’’ identical residues in all sequences.
doi:10.1371/journal.ppat.1000995.g001
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cells but were not able to detect the expression of NUE during
infection most likely due to a low level of expression (data not
shown). However, we were able to detect NUE in the lysates of
infected cells by Western blot (Fig. 2B). In these studies, we
infected HeLa cells with C. trachomatis for 3–44 h, lysed the cells
and probed for NUE. NUE expression is first detectable at late
timepoints (between 18 and 25 h). This is in agreement with
transcriptome studies describing peak mRNA expression at 18 h
post-infection [26]. By comparison, we found expression of
chlamydial heat shock protein 60 (Hsp60) at earlier timepoints
as expected of chlamydial proteins expressed earlier in infection.
While these data suggest that NUE expression occurs late in
infection, we cannot rule out the possibility that expression of
NUE occurs at earlier timepoints but is undetected due to low
abundance.
Transfected NUE localizes to the nucleus of mammalian
cells
Due to the limitations of working with Chlamydia itself, we
generated both N-terminus FLAG- and GFP-tagged NUE
constructs. We found that, regardless of the tag, NUE localized
to the nucleus of transfected cells, both murine and human
(Fig. 3A, GFP data not shown). Sequence analysis of the protein
revealed two potential nuclear localization sequences (RRR at
position 121 and KHRKKR at position 206). We therefore
generated two C-terminal truncation mutants of NUE, NUED12
and NUED122 that exclude either one (NUED12) or both
(NUED122) of these sequences. When HeLa cells were transfected
with the FLAG-tagged truncated proteins, both demonstrated a
loss of predominant nuclear localization compared to NUE but to
varying degrees (Fig. 3B and C). NUED122 completely lost
exclusive nuclear localization (0% exclusive nuclear localization)
while NUED12 had an intermediate phenotype (30% of
transfected cells demonstrated predominant nuclear localization
compared to 74% of full-length NUE). Both mutants are expressed
diffusely throughout the cell, including in the nuclear space
(confirmed by Z-stack analysis, data not shown). Full-length
FLAG-NUE has a molecular weight of 28 kDa and could
potentially diffuse into the nucleus unassisted. However, the loss
of nuclear enrichment with truncated mutants verifies that NUE
nuclear localization cannot be solely attributed to low molecular
weight. Additionally, we fractionated the transfected cells to probe
cytosolic versus nuclear soluble and nuclear insoluble fractions
(Fig. 3D). We found, in agreement with the immunofluorescence
data, that NUED122 was poorly retained in the nucleus. NUE and
NUED12 appeared equally retained in the soluble nuclear
fraction. Interestingly, while both NUE and NUED12 were
detected in the nuclear insoluble, the full-length NUE showed
slightly higher abundance in this fraction. To control for the purity
of the fractions, we reprobed the membrane for Rab-GDP
dissociation inhibitor b (GDIb, found only in the cytosolic
fractions), poly (ADP-ribose) polymerase 1 (PARP1, found only
in the nuclear fractions) and histone H3 (found only in the nuclear
insoluble fractions). Taken together, we conclude that while the
last 12 amino acids take part in NUE distribution to the nucleus,
other internal features such as an internal nuclear localization
signal or the SET domain itself, are also required for NUE
accumulation in the nucleus.
NUE is translocated to the host cell nucleus during
infection
To determine the localization of NUE during infection, we
infected HeLa cells for 20, 25, 30 or 40 h and isolated nuclei by
hypotonic cell lysis followed by low speed centrifugation. When we
probed the cytosolic (including bacteria) and nuclear fractions by
Western blot, NUE was clearly found in the nucleus of infected
cells, particularly at late timepoints (Fig. 4A). In contrast, the
chlamydial proteins EF-Tu (an abundant protein retained in the
bacteria) was absent in our nuclear fractions excluding the
possibility that these fractions were contaminated with bacteria.
As expected, we found NUE (as well as EF-Tu) in the cytosolic
fraction, presumably at a stage of synthesis and secretion. To
control for the purity of our fractions, we reprobed the membrane
for GDIb (found only in the cytosolic fractions) and PARP1 (found
only in the nuclear fractions). In tandem with our previous results
demonstrating the presence of a TTS signal in NUE (Fig. 2A), we
conclude that NUE is secreted via TTS and translocated to the
nucleus of host cells.
To further characterize the nuclear localization of NUE, we
transfected cells with GFP-NUE for 24 h, separated out the nuclei
and then fractionated the nuclei into soluble versus chromatin-
associated protein as diagrammed in Fig 4B. We found NUE in
both the cytosolic and nuclear fractions, as supported by our
Figure 2. NUE is secreted from bacteria and detected during late infection. (A) Chlamydia trachomatis NUE and its C. pneumoniae and C.
caviae homologs were fused to the Cya reporter protein and expressed in Shigella flexneri ipaD (constitutive TTS) or mixD (defective TSS) strains.
Bacteria were pelleted and both pellet and supernatant were loaded on SDS-PAGE gels, transferred to a PVDF membrane and probed with anti- Cya
(to detect chlamydial fusion proteins), anti-IpaD (Shigella secreted protein) or anti-CRP (Shigella non-secreted protein) antibodies. (B) HeLa cells were
infected with C. trachomatis for the times indicated, lysed and analyzed by Western blot using antibodies for the chlamydial proteins NUE and Hsp60.
Actin was used to ensure equal loading of samples. All results shown are representative of at least 2 separate experiments.
doi:10.1371/journal.ppat.1000995.g002
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chromatin fraction (Fig. 4C). As a positive control, we found
similar distribution of myc-tagged Suv39H1, a well-characterized
histone methyltransferase. In contrast, GFP was found in the
cytosolic and soluble nuclear fractions but very little to none was
found in the chromatin fraction demonstrating that this association
is specific to NUE. We reprobed our membrane with anti-histone
H3 to demonstrate histone enrichment in our chromatin fraction
and which served as an equal loading control. We conclude that
NUE is localized to the nucleus and associated with chromatin,
supporting our hypothesis that it plays a role in chromatin
function. To address whether NUE is found associated with
Figure 3. NUE localizes to the host cell nucleus. (A) HeLa or 3T3 cells were transfected with FLAG-NUE, fixed with paraformaldehyde,
permeabilized and analyzed by immunofluorescence using anti-FLAG antibody and Hoescht dye to stain nuclei. (B) HeLa cells were transfected with
NUE or the C-terminal truncation mutants NUED12 and NUED122 and treated as above for immunofluorescence analysis. (C) The number of
transfected cells demonstrating predominant nuclear localization was divided by the number of total transfected cells and multiplied by 100 to
determine % nuclear localization. Each experiment was performed 3 times with .500 transfection events counted for each protein. Error bars reflect
the difference in calculated percentage among the 3 separate experiments. (D) Western blot analysis of transfected cells. HeLa cells were transfected
with FLAG-tagged NUE, NUED12 or NUED122 for 24 h and cells were then fractionated into cytosolic and nuclear fractions. Protein concentration was
measured by Bradford and for each fraction 20 mg of protein was loaded on a gel. The remaining pellet after protein extraction from nuclei was also
analyzed as the nuclear insoluble fraction. NUE distribution in the different fractions was analyzed by Western blot using anti-FLAG antibody. Anti-
GDIb (cytosolic), anti-PARP1 (nuclear) and anti-H3 (nuclear insoluble) were used to demonstrate purity of the fractions.
doi:10.1371/journal.ppat.1000995.g003
C. trachomatis NUE Methylates Histones
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trachomatis for 40 h and fractionated the cells into cytosolic, nuclear
soluble and chromatin fractions as was done in the transfected
cells. Importantly, we found NUE is associated with chromatin in
infected cells (Fig. 4D). The absence of EF-Tu confirms this signal
is not due to bacterial contamination of the chromatin-associated
fraction.
NUE is a functional histone methyltransferase
SET domain proteins methylate histones using S-adenosyl-L-
methionine (SAM) as a methyl donor. In order to determine the
enzymatic activity of NUE, we performed in vitro methyltransferase
assays using GST-NUE purified from E. coli and mammalian
histones as a potential substrate. We found that NUE methylated
multiple core histones (Fig. 5A and B). NUE-mediated methylation
is dependent both on the amount of histone substrate (Fig. 5A,
lanes 1–4) and on the concentration of enzyme (Fig. 5A, lanes 5–
8). As a positive control, we used the histone H4 methyltransferase
protein arginine methyltransferase I (PRMT1) (Fig. 5A, lane 9). To
assess the individual histones modified by NUE, we repeated the
assay using individual recombinant histones. NUE methylated
H2B, H3 and to a lesser extent H4, but not H2A (Fig. 5B). Clearly,
NUE has a stronger activity towards H4 when all core histones are
present as in Fig. 5A. The preference of HMTs for one form of
histone over another (i.e., isolated histones versus recombinant) has
been reported and is presumably due to slight variations in
proteins expressed in mammalian versus bacterial cells [27,28].
The histone-like chlamydial protein Hc1 plays a role in DNA
condensation during the bacterial life cycle. To test the possibility
that Hc1 is a substrate for NUE, we conducted in vitro methylation
assays using various concentrations of purified recombinant Hc1
in the presence of NUE. NUE did not methylate Hc1 at any
concentration tested (Fig. 5C). Due to the difficulties in growing
and purifying Hc1, we were not able to test concentrations in
molar excess of mammalian histones. However, using H2B as our
histone control, we clearly demonstrated the preference of NUE
for mammalian histones over chlamydial Hc1 when used at equal
concentrations.
Figure 4. NUE is found in the nucleus of infected cells and associates with chromatin. (A) HeLa cells were infected with C. trachomatis for
20, 25, 30 or 40 h. Nuclei were isolated as described in the Method section and both cytosolic and nuclear fractions were analyzed by Western blot
using anti-NUE antibody. The membrane was stripped and re-probed for GDIb as a cytosolic marker, PARP1 as a nuclear marker and the chlamydial
protein EF-Tu to ensure the absence of bacteria in the nuclear fraction. Blots are representative of 2 separate experiments. (B) A schematic of the
extraction protocol used to detect chromatin-associated proteins. (C) HeLa cells were transfected with GFP-NUE or GFP only as a negative control.
Nuclei were separated from the cytosolic fraction of transfected HeLa cells. The nuclei were resuspended in 3 mM EDTA to extract soluble nuclear
proteins versus chromatin-associated proteins. Samples were analyzed by Western blot using anti-GFP. HeLa cells transfected with Suv39H1 were
used as a positive control and anti-Suv39H1 was used to detect the protein. Histone H3 was used to ensure chromatin enrichment in our chromatin
fraction. Blots are representative of 3 separate experiments. (D) HeLa cells were infected with C. trachomatis for 40 h and analyzed for chromatin-
association of NUE as in (C). Histone H3 was used to demonstrate purity of our chromatin-associated fractions and EF-Tu was used to control for
bacterial contamination. Blots are representative of 2 separate experiments.
doi:10.1371/journal.ppat.1000995.g004
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While conducting our in vitro methylation assays, we consistently
detected strong methylation of NUE itself (automethylation). As
the amount of histone substrate increased, the level of auto-
methylation decreased (Fig. 5A) suggesting competition between
substrates. To confirm this was a bona fide methylation event, we
performed the assay using excess amounts of non-radioactive SAM
to compete away the incorporation of
14C-labelled SAM-derived
methyl groups (Fig. 6A). Additionally, we wanted to ensure that
the automethylation signal of NUE was not solely due to
methylation of the GST moiety. We therefore performed in vitro
methylation assays using NUE in the presence of GST only or a
second GST-labeled chlamydial protein, GST-CT529 (Fig. 6B).
As expected, there was some weak methylation of GST itself but
only when GST was in excess compared to GST-NUE (3:1 or 5:1
molar excess). To an even lesser degree, we saw methylation of
GST-CT529. We also detected GST methylation in the GST-
CT529 reactions due to the presence of GST alone contaminating
our purified GST-CT529 (Fig. 6B, Coomassie stained gel). We
conclude that the strong automethylation of GST-NUE occurs
primarily within the NUE sequence.
NUE automethylation regulates its activity towards
histones
To determine which residue(s) is the target of automethylation, we
conducted non-radioactive in vitro methyltransferase assays using
Figure 5. NUE methylates mammalian histones in vitro. (A–C) Recombinant GST-NUE was purified from E. coli and incubated with either core
histones (A), individual recombinant histones (B) or recombinant His-tagged chlamydial protein Hc1 (C) in the presence of
14C-SAM for 1 h at 30uC.
Samples were then separated on a 15% SDS-PAGE gel and stained with Coomassie blue prior to gel dehydration and 24 h exposure to capture
radioactive events. PRMT1, a histone H4 methyltransferase, was used as a positive control in panel A. Various concentrations of histone H2B were
used as a positive control in panel C.
doi:10.1371/journal.ppat.1000995.g005
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was incubated in the presence of
14C-SAM and increasing amounts of non-radioactive SAM for 1 h at 30uC. Samples were then separated by SDS-
PAGE electrophoresis and stained with Coomassie blue prior to gel dehydration and 24 h exposure to capture radioactive events. (B) NUE
automethylates outside the GST moiety. GST-NUE was incubated with chlamydial protein GST-CT529 (1:4 or 1:2 molar ratio) or GST alone (1:5, 1:3 or
1:1 molar ratio). Samples were then treated as in panel A. (C) NUE mutants have diminished activity towards histones. NUE, NUED12, NUEGG (KKRGG)
or NUEAA (KKRAA) were incubated in the presence of core histones for 1 h at 30uC. Samples were then treated as in panel A. All gels are
representative of at least 2 independent experiments.
doi:10.1371/journal.ppat.1000995.g006
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SAM. Comparison of these samples by mass-spectrophotometer
revealed increased methylation in the presence of SAM of a peptide
fragment containing two adjacent lysines, K209 and K210 (data not
shown). The analysis could not distinguish between a di-methylation
of one of these lysines or a single methylation event of both. We
therefore generated mutants with both lysine residues mutated to
either GG (NUEGG) or AA (NUEAA). We also used our C-terminal
truncation mutant NUED12 that lacks both K209 and K210 (see
diagram Fig. 6C). We hypothesized that these mutations would not
affect catalytic activity as the residues modified lie outside of the SET
domain. Indeed, when we performed in vitro methylation assays using
these mutants, each was able to automethylate to some degree
demonstrating enzyme function is still intact (Fig. 6C). The residual
automethylation is most likely attributed to the observation that the
GST moiety itself can be methylated by NUE (Fig. 6B) and/or the
possibility of alternative sites of methylation in the absence of the
preferred residues.However, the decreasein signal compared to wild-
type NUE suggests K209 and/or K210 serve as sites of automethyla-
tion. All three of the mutants demonstrated weaker histone
methylation than the wild-type protein even when used at twice the
concentration (Fig. 6C). These results suggest automethylation
enhances NUE enzymatic activity t o w a r d si t ss u b s t r a t ea sl o s so f
two lysines targeted for methylation correlated with a decrease in
histone methylation. Interestingly, the NUEGG mutant was slightly
less impaired both in automethylation and towards histone substrate
than the other two mutants. This suggests that this particular
mutation overcomes to some extent the need for methyl groups on
residues 209 and 210 to reach full enzymatic activity.
Discussion
Bacterial effector proteins play crucial roles in pathogenicity. In
this work, we have identified a new chlamydial effector protein,
NUE, which contains a SET domain predictive of histone
methyltransferase activity. We identified NUE as a novel TTS
substrate of chlamydiae based on (i) the presence of NUE in the
host cell nucleus during C. trachomatis infection, indicative that the
protein is secreted outside the inclusion and (ii) the presence of a
TTS signal in the N-terminal part of NUE from three different
chlamydiae species. In vitro enzymatic assays confirmed the activity
of NUE as a histone methyltransferase that modified mammalian
histones H2B, H3 and H4. This is the first identified bacterial SET
domain protein to directly enter the nucleus of the host cell and
target mammalian histones.
Our observation that NUE methylates multiple histones is
unusual but not unique. There are a growing number of
mammalian examples in which a single histone methyltransferase
has multiple histone and/or non-histone substrates. G9a is a well-
characterized human SET domain protein that methylates both
H3K9 and H3K27 [13]. A separate study identified G9a
methylation of several non-histone proteins including chromodo-
main Y-like protein, widely interspaced zinc finger motifs protein,
Cockayne syndrome group B protein and G9a itself (automethyla-
tion) [14]. Although not a SET domain protein, protein arginine
N-methyltransferase 8 (PRMT8) is a histone methyltransferase that
methylates both histones H2A and H4 and automethylates [29].
Interestingly, other pathogen effector proteins have been reported
to have multiple mammalian targets. For example, Listeria
monocytogenes induced dephosphorylation of histone H3 as well as
deacetylation of both histones H3 and H4 [30]. In a separate
study, the Shigella flexneri effector OspF was identified as a
phosphatase that dephosphorylates two mitogen-activated protein
kinases, ERK1 and p38, which ultimately leads to inhibition of
histone H3 phosphorylation [31]. It is therefore entirely feasible
that bacteria use their limited genome to target multiple substrates
with a single effector. Studies are ongoing to determine the in vivo
lysines targeted by NUE in order to analyze its specific effect on
host cell chromatin.
Chlamydiae histone-like proteins Hc1 and Hc2 play a role in
compacting DNA during the RB to EB transition [21,22]. It was
previously reported that Hc1 acts as a substrate of the C. pneumoniae
NUE homolog in addition to histone H3 (other histones were not
tested) [32]. To the contrary, we did not find methylation of Hc1
in our in vitro studies. Slight variations in protocol may contribute
to the observed differences. Murata et al. used C. pneumoniae NUE
with truncated Hc1 fragments as substrates. We used C. trachomatis
with full-length Hc1. Additionally, we found NUE to be secreted
by TTS, and substrates of TTS are often retained unfolded before
secretion via association with a chaperone protein. If this is true for
NUE, enzymatic activity within the bacteria would be unlikely.
In addition to its activity as a histone methyltransferase, NUE is
an automethyltransferase. To date, there are two SET domain
proteins reported to automethylate. G9a was shown to methylate
its K239 residue [33]. Mutation analysis revealed the importance
of this methylation event for G9a interaction with heterochroma-
tin protein 1 (HP1) which therefore increased the function of the
protein to act as a transcriptional repressor. In contrast,
automethylation was shown to have little effect on the methyl-
transferase activity of Metnase but inhibited its decatenation
activity [34]. Additionally, two non-SET domain HMTs, PRMT6
and PRMT8, automethylate. Automethylation of PRMT8 was
shown to inhibit its function as a methyltransferase and the
automethylation function of the fourth example, PRMT6, remains
unexplored [29,35]. Here we observed that mutation of the
putative automethylation sites of NUE resulted in a decreased
activity towards histone substrates. This suggests automethylation
of NUE may enhance its methyltransferase activity perhaps by
increasing its affinity for the target substrates.
One important question left opened by our study is the identity
of the genes regulated by NUE translocation in the nucleus during
Chlamydia infection. In the absence of a genetic system to
manipulate Chlamydia it is difficult to answer. We have observed
that NUE is expressed in low abundance during infection, a
condition which is not reproduced by transfection approaches.
Transcriptional studies have shown that, not surprisingly,
numerous host genes are upregulated or downregulated during
Chlamydia infection [36,37]. One study that addresses global
changes on host gene expression on a large time scale indicates
that about 150 genes are up-regulated 36 hrs after infection of
HeLa cells by C. trachomatis L2, against only about 75 genes 24 hrs
post infection [38]. These data are in favor of the existence of
mechanisms of control of gene expression by the bacteria that
might be turned on only late in the infectious cycle, when NUE is
expressed. While the cell is responding to dramatic changes
triggered by infection, only some of its transcriptional response
may result directly from NUE activity. Identification of NUE
specific targets might come from the identification of its nuclear
binding partner(s), which we are currently undertaking. We are
also developing anti-NUE antibodies that would be suitable for
chromatin immunoprecipitation approaches with infected cells.
SET domain proteins are present in all eukaryotes, and the few
examples of such domains in bacterial proteins were initially
interpreted to be the result of horizontal gene transfer. A more
recent study favors the hypothesis that prokaryotic SET domain
proteins evolved independently from a bacterial ancestor [39]. While
our findings do not solve this intriguing question, we do show that the
chlamydial SET domain protein evolved into a secreted protein
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to sustain chronic infections presents an opportunity and motive for
the bacteria to exert long-term epigenetic control of host cells. Any
link between cleared chlamydial infection and dysregulation of
genetic information due to epigenetic reprogramming, such as in
cancer, will be challenging to establish as infections are often not
diagnosed. Regardless of the long term implications, taking control of
the host cell at the level of gene expression is certainly advantageous
for a bacterium. Manipulating the histone code is one way to achieve
this, and we can speculate that other pathogens that possess a SET
domain protein may employ this strategy to sustain their own
development.
Materials and Methods
Cell culture and chlamydial infection
HeLa and 3T3 cells (originally obtained from the ATCC) were
cultured in DMEM culture medium supplemented with 5% fetal
calf serum at 37uC and 5% CO2. Chlamydia trachomatis serovar L2
(originally obtained from ATCC) were harvested from infected
cells as described previously with a few modifications [40]. Briefly,
the bacteria were propagated in HeLa cells for 48 h. The cells
were pelleted by centrifugation, resuspended in 10 ml of ice-cold
SPG buffer (218 mM sucrose, 3.76 mM KH2PO4, 7.1 mM
K2HPO4, 4.9 mM glutamate, pH 7.4) and then passed through
a 22 G needle to lyse the mammalian cells. The resulting
suspension was centrifuged at 5006g for 10 min to remove
unbroken cells and nuclei. The new supernatant was centrifuged at
250006g for 30 minutes at 4uC to collect the bacteria. The
bacteria pellet was subsequently homogenized, resuspended in ice-
cold SPG, aliquoted and stored at 280uC. Infection MOIs were
determined by serial dilution of bacterial preps.
Plasmids
The E. colistrain TG1wasused for plasmid constructions.S. flexneri
and E. coli strains were grown in Luria-Bertani (LB). Full-length and
C-terminal truncations of NUE were generated by PCR amplifica-
tion of NUE from C. trachomatis D/UW-3/CX genomic DNA and
were introduced into pDEST Gateway vectors (Invitrogen) by
recombination as specified by the manufacturer’s protocol. Amino
acid substitution mutants were generated using Strategene Quick-
change Mutgenesis Kit and verified by sequence analysis.
Secretion assay and antibody production
Strains SF401 and SF620 are derivatives of M90T, the virulent,
wild-type strain of S. flexneri 5, in which the mxiD and ipaB genes,
respectively, have been inactivated [41]. The 59 part of nue
(including the first 29 codons for CT737, the first 27 codons for
CPn0878 and the first 14 codons for CCA00889) were amplified
by PCR and cloned in the puc19cya vector as described [42].
Secretion assays were performed on 30 ml of exponentially grown
cultures as described previously [42]. Monoclonal antibody against
Cya and polyclonal antibodies against CRP and IpaD were
generously given by Drs. N. Guiso, A. Ullmann and C. Parsot,
respectively (Institut Pasteur, Paris).
For NUE antibody production, the nue gene was amplified by
PCR and cloned in the NcoI and KpnI sites of pQE-TriSystem
vector (Qiagen). His-tagged NUE was grown in E. coli, purified
using Ni-nitrilotriacetic acid agarose beads (Qiagen) and used as
immunogen for the production of specific polyclonal antibodies in
New Zealand White rabbits (Agro-Bio, La Ferte ´ Saint-Aubin,
France). The resulting rabbit anti-serum was then purified against
GST-tagged NUE to obtain NUE antibody.
Immunofluorescence
For immunofluorescence studies of transfected cells, 3T3 or
HeLa cells were plated on glass coverslips and transfected using
FuGene 6 (Roche) at a reagent to DNA ratio of 3:1. After 24 or
48 h transfection, cells were washed once with PBS, fixed with 4%
paraformaldehyde and permeabilized with 0.3% Triton X-100 for
5 min. Coverslips were then incubated with anti-FLAG (Sigma
Aldrich) antibody in the presence of 0.1% bovine serum albumin,
washed, incubated with Alexa Fluor 488 secondary antibody
(Molecular Probes), washed repeatedly and mounted on glass
slides using Mowiol containing 0.5 mg/ml Hoechst DNA stain.
Nuclear isolation and Western blots
Infected(MOIof1:1)ortransfected HeLa cellswerewashedonce
with PBS, pelleted and resuspended in buffer A (10 mM HEPES,
pH 7.9, 10 mM KCl, 0.1 mM EDTA, 1 mM EGTA +protease
inhibitor cocktail (Sigma, P8340)) for 10 min before addition of
0.2% NP-40 and passage through a 26 G syringe. Nuclei were
pelleted at 8006g for 5 min, washed 16with buffer A, resuspended
in RIPA buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 2 mM
EDTA, 1% NP-40, 0.5% Na-deoxycholate, 0.1% SDS + protease
inhibitor cocktail) for 30 min and centrifuged at 160006g for
10 min. Proteinconcentrationswere determinedusing theBradford
assay (Bio-Rad) and equal quantities from the cytosolic and nuclear
fractions were loaded for analysis by western blot. Monoclonal anti-
poly ADP ribose polymerase 1 (PARP1) antibody was purchased
from Trevigen,monoclonalantibodyagainst chlamydialEF-Tuwas
a kind gift from Y-X Zhang (Boston, USA) and polyclonal rabbit
antibody against GDIb was a kind gift from B. Goud (Institut Curie,
France).
Separation of soluble nuclear fraction versus chromatin-
associated proteins was done following the nuclear isolation
protocol described above. Once isolated, nuclei were resuspended
in buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT) for
30 min and centrifuged at 17006g for 5 min. Supernatants were
collected as soluble nuclear fraction and the chromatin pellet was
washed 2 times in buffer B before resuspension in 16 sample
buffer. All samples were boiled for 5 min prior to loading for
separation on several identically loaded SDS-PAGE gels. All gels
were then transferred to a PVDF membrane, blocked in 5% BSA
for 1 h and incubated with appropriate antibodies. Rabbit
polyclonal anti-Suv39H1 antibodies were from Upstate (#07-
550), anti-Histone H3 antibodies from Sigma (H0164).
Protein purification and HMT assay
GST-tagged proteins (NUE or NUE mutants) were produced in
E. coli grown to log phase and induced with 0.5 mM isopropyl-
beta-D-thiogalactopyranoside (IPTG) overnight at 20uC. Bacteria
were centrifuged at 38006g for 15 min at 4uC, resuspended in
lysis buffer (50 mM Tris pH 7.5, 100 mM NaCl, 1 mM EDTA,
10% glycerol, 0.01% Triton X-100, 1 mM PMSF) for 30 min,
sonicated and centrifuged at 172006g for 20 min at 4uC.
Supernatants were incubated with glutathione sepharose beads
(Pierce) for 1 h at 4uC, washed 3 times and protein was eluted
from the beads using 20, 50 and 100 mM reduced glutathione (pH
adjusted to 8). Protein containing fractions (determined by
Coomassie blue staining) were pooled, concentrated and measured
by Bradford assay to determine final protein concentration. His-
tagged Hc1 (hctA plasmid was the generous gift of Dr. Ming Tan,
University of California Irvine) was produced in E. coli grown to
log phase and induced with 0.2% L-arabinose for 3 h. Bacteria
were centrifuged, resuspended in lysis buffer (10 mM Tris pH 8,
300 mM NaCl, 2 mM imidazole plus protease inhibitors) and
sonicated to ensure lysis. After centrifugation, supernatants were
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eluted with 10, 50, 250 or 500 mM imidazole. Eluate was then
dialysed with storage buffer (10 mM Tris pH 8, 10 mM MgCl2,
0.1 mM EDTA, 100 mM NaCl), concentrated and protein
concentration was measured by Bradford assay (Bio-Rad).
HMT assays were performed using 4 mgo fr e c o m b i n a n tN U E
and/or NUE mutants in equal or molar excess. Assays were carried
out in 25 mL of assay buffer (50 mM Tris pH 8, 20 mM KCl,
250 mM sucrose, 10 mM MgCl2, 1 mM DTT) plus or minus core
histones (Sigma Aldrich, H9250) or individual recombinant histones
(New England Biolabs) and S-[methyl-C14]-adenosyl-L-methionine
(PerkinElmer) for 1 h at 30uC. Samples were boiled for 5 min before
migration on 15% SDS-PAGE gels. All gels were stained with
Coomassie blue to visualize protein loading before drying and 24 h
exposure for analysis of radioisotope incorporation. Control proteins
GST-CT529 and GST only were purified from E. coli as described
above for GST-NUE.
For mass-spectrophotometric analysis, after incubation of GST-
CT737 with SAM and in-gel digestion of the reaction product
with trypsin, the lysine residues and the N-termini were labeled
with nicotinic acid and then subjected to small scale reverse phase
chromatography. The sample was then eluted with a modified step
gradient from 10–65% acetonitrile and each fraction was spotted
onto a MALDI plate. The spectra were acquired from each plate
and analyzed using PROFOUND and PEPMAP programs to
identify potentially methylated peptides. MS/MS (fragmentation)
spectra were taken of the top 15 peptides per fraction and were
searched using MASCOT or X!Tandem.
Accession numbers/ID numbers for proteins mentioned
in the text
NUE in C. caviae – NP_829751.1
NUE in C. pneumoniae – NP_300935.1
NUE in C. abortus – YP_220244.1
NUE in C. trachomatis serovar D – NP_220256.1
NUE in C. muridarium – NP_296494.1







Figure S1 Purified NUE antibody is protein-specific. NUE
antibody was generated and purified as described in Material and
Methods. Lysates from non-infected HeLa cells (‘‘2’’) or cells
infected with C. trachomatis (‘‘+’’) for 48 hours were loaded on a
SDS-PAGE gel, transferred to a PVDF membrane and probed
with anti-NUE (1
st panel), anti-NUE in the presence of 5 mg/ml
NUE purified protein (2
nd panel) or anti-NUE in the presence of
5 mg/ml CT671 purified protein (3
rd panel), an irrelevant protein
purified in the same conditions as NUE. The boxed portion of the
gel indicates the predicted location of NUE (predicted molecular
weight is 25 kDa).
Found at: doi:10.1371/journal.ppat.1000995.s001 (0.65 MB TIF)
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